A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
about
XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose.Treatment of relapsed/refractory acute myeloid leukaemia in adults.Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer.A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.Karyopherins in cancer.Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial.Nuclear Export Inhibition for Pancreatic Cancer Therapy.Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumorsNuclear transport inhibition in acute myeloid leukemia: recent advances and future perspectivesPhase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
P2860
Q47113773-8F431B76-740B-41DC-8D19-CBAD19C36D5CQ47741553-4B26090F-3D5C-4C88-A7D4-DF836B46600CQ48743003-5593F7C8-C902-4887-A4BE-24147FF38105Q49188547-5C842DDB-3476-4254-9AED-9CA7817CE17CQ50134836-5CF32C62-C877-493B-AD54-5132343E7B33Q54109032-AA7E71ED-765E-4D82-B2AD-F20CDA1B9765Q55040338-806480F5-0DEE-404F-ADBB-1625B20E4331Q57099831-204D1FDE-1B73-4999-8E1C-E759568673B8Q58555302-1A32A8C5-865D-4293-90BE-38C8137494FBQ58707427-FF4FE394-87A1-4F20-BD93-DA1B932B85C5
P2860
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
@en
type
label
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
@en
prefLabel
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
@en
P2093
P2860
P50
P1433
P1476
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
@en
P2093
Boris Klebanov
Jean-Richard Saint-Martin
Lynn Savoie
Martin Gutierrez
Michael Kauffman
Nashat Gabrail
Nina Wagner-Johnston
Ramiro Garzon
Richard Stone
P2860
P304
P356
10.1182/BLOOD-2016-11-750158
P407
P577
2017-03-23T00:00:00Z